D
Darcy A. Lamb
Researcher at Saskatchewan Health
Publications - 13
Citations - 264
Darcy A. Lamb is an academic researcher from Saskatchewan Health. The author has contributed to research in topics: Cohort study & Hazard ratio. The author has an hindex of 6, co-authored 13 publications receiving 249 citations. Previous affiliations of Darcy A. Lamb include University of Saskatchewan.
Papers
More filters
Journal ArticleDOI
Practice Change Challenges and Priorities: A National Survey of Practising Pharmacists
TL;DR: A survey among practising pharmacists in Canada found that pharmacists have responded positively to the proposed vision for the future of pharmacy and are eager to move away from the traditional dispensing role to an expanded clinical role that more fully utilizes their unique skills and knowledge.
Journal ArticleDOI
Changes in Adherence to Evidence-Based Medications in the First Year After Initial Hospitalization for Heart Failure Observational Cohort Study From 1994 to 2003
Darcy A. Lamb,Dean T. Eurich,Finlay A. McAlister,Ross T. Tsuyuki,William Semchuk,Thomas W. Wilson,David F. Blackburn +6 more
TL;DR: One-year adherence to BB and ACEI/ARB is improving over time in patients discharged after first heart failure hospitalization, and subjects discharged in 2003 were significantly more likely to exhibit optimal adherence to a BB or an ACEI orARB than those prescribed therapy in 1994/1995.
Journal ArticleDOI
Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada.
Charity Evans,Dean T. Eurich,Darcy A. Lamb,Jeff Taylor,Derek Jorgenson,William Semchuk,Kerry Mansell,David F. Blackburn +7 more
TL;DR: Adherence to statin therapy among subjects patronizing different types of community pharmacy categories in Saskatchewan, Canada, between 2000 and 2005 was described, and pharmacy category type was significantly associated with statin adherence.
Journal ArticleDOI
Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
David F. Blackburn,Darcy A. Lamb,Dean T. Eurich,Jeffrey A. Johnson,Thomas W. Wilson,Roy Dobson,James L. Blackburn +6 more
TL;DR: The low event rates for all cohorts suggest that atenolol has not been associated with a significant burden of cardiovascular morbidity or mortality in its traditional role for uncomplicated hypertension.
Journal ArticleDOI
Risk of Heart Failure in Patients With Recent-Onset Type 2 Diabetes: Population-Based Cohort Study
Alexander A. Leung,Dean T. Eurich,Darcy A. Lamb,Sumit R. Majumdar,Jeffrey A. Johnson,David F. Blackburn,Finlay A. McAlister +6 more
TL;DR: The incidence of HF is relatively high within 5 years of diabetes onset, calling into question the ease with which individuals with diabetes "at low risk of HF" can be identified.